1-((4-Amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride, 95.0%, 5g

Trichloro(phenylethyl)silane (mixture of isomers)>98.0%(GC)25g

Methyl 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 250mg

Cajas cuadradas ROTILABO®, 1000 ml, 10 Unidad(es)

(R)-3-Cbz-2-Oxo-imidazolidine-4-carboxylic acid, 95.0%, 5g

Dietilcetona, min 99%, para síntesis, 2,5 L, envase de vidrio

5,6,7,8-Tetrahydro-3H-benzo[4,5]thieno[2,3-d]-pyrimidin-4-one, 90.0%, 5g

Buprofezin>98.0%(HPLC)(T)25g

2-Fluoro-2-(p-tolyl)acetic acid, 95%, 100mg

3-Bromo-4-hydroxybenzonitrile>95.0%(GC)5g

METHYL 4-CHLORO-5,8-DIMETHYLQUINOLINE-2-CARBOXYLATE, 95.0%, 1g

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester, 97%, 25g

(3-Chloro-2-formylphenyl)boronic acid, 97%, 1g